Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Arjuna bark from Terminalia arjuna contains high concentrations of flavonoids, tannins, and triterpenoids that provide cardioprotective effects through antioxidant mechanisms and coronary artery function enhancement. The bark's flavonoid compounds demonstrate significant free radical scavenging capacity at 199.00 mg quercetin equivalent per gram of dried extract.
Reported Benefits (Provisional)
Origin & History
Arjuna Bark, derived from *Terminalia arjuna*, is indigenous to the Indian subcontinent, thriving along riverbanks and in dry riverbeds of tropical and subtropical regions. Revered in Ayurvedic medicine, this bark is a cornerstone for cardiovascular health, valued for its ability to strengthen heart muscles and support circulatory function.
Research Narrative (Provisional)
Arjuna Bark is extensively documented in pharmacological research for its cardioprotective, antioxidant, and antihypertensive properties. Clinical studies support its role in improving heart function, reducing LDL cholesterol, and modulating blood pressure, validating its traditional Ayurvedic applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Triterpenoids: Arjunolic acid, arjunic acid, arjunetin (Cardiotonic, hepatoprotective) - Flavonoids: Antioxidant, anti-inflammatory, and lipid-regulating effects. - Tannins, Saponins, Glycosides: Contribute to its diverse therapeutic properties. - Minerals: Calcium, Magnesium, Zinc, Copper (Support cardiovascular and enzymatic functions).
Reported Mechanism (Provisional)
Arjuna bark's triterpenoids provide cardiovascular protection while flavonoids demonstrate potent antioxidant activity with free radical scavenging capacity measured at 199.00 mg quercetin equivalent/g dried extract. The bark's tannins and phenolic compounds exert antimicrobial effects by increasing bacterial cell membrane permeability, causing cellular content leakage and cell death. Bioactive constituents including terminoside A and arjunoglycosides induce apoptosis in abnormal cells and suppress inflammatory pathways.
Clinical Narrative (Provisional)
Current research on Arjuna bark consists primarily of in vitro studies and phytochemical analyses rather than controlled clinical trials in human subjects. Laboratory studies demonstrate significant DNA damage protection and protein oxidation prevention through ethanolic extracts and various fractions including dichloromethane, ethyl acetate, and butanol preparations. While extensive pharmacological research documents cardioprotective, antioxidant, and antihypertensive properties, quantified clinical trial outcomes with specific sample sizes and statistical significance data are limited. The evidence base would benefit from more rigorous human clinical trials to validate traditional Ayurvedic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.